Document Type : Original Article

Authors

• M. Dadashi ¹
• S. Momtazi ¹
• V. Yousefi Asl ²
• A.A. Asghar Nejad Farid ³
• B. Gharraee ³

¹ Assistant Professor, Department of Clinical Psychology, Zanjan University of Medical Sciences, Zanjan, Iran

² M.A. of Clinical Psychology, Zanjan University of Medical Sciences, Zanjan, Iran

³ Associate Professor of Clinical Psychology, Behavior Science and Mental Health School, Iran University of Medical Sciences, Tehran, Iran

Abstract

PTSD is an acute psychological reaction to traumatic events. Non-drug treatments are considered to be as first-line treatments for PTSD and basically should be complementary treatment programs for patients with PTSD. However, some patients do not adequately respond to non-drug treatments or leave treatment with debilitating symptoms. However, evidence of the effectiveness of non-drug treatments in combination with drug therapy is not yet completed. The aim of this research was to investigate the effectiveness of combination of pharmachothrapy with metacognitive therapy versus pharmachotherapy in patient with posttraumatic stress disorder. Six males were selected by convenient sampling and randomly assigned to two treatment groups. The methodology was a multiple-baseline experimental single case study. subjects completed Clincian-Adminestered PTSD Scale (CAPS), Beck Depression Inventory (BDI-II),Thought Control Questionnaire (TCQ) at pre-treatment(baseline), treatment (4 and 8 sessions), post-treatment (twelfth) and at follow-up (two months after treatment). Both combination of pharmachothrapy with metacognitive therapy and pharmachotherapy in patient with posttraumatic stress disorder are effective, and combination of pharmacotherapy with metacognitive therapy can be more effective. Combination of pharmacotherapy with metacognitive therapy can be more effective than pharmachotherapy in reducing posttraumatic stress disorder symptoms.


Materials and Methods: Six males were selected by convenient sampling and randomly assigned to two treatment groups. The methodology was a multiple-baseline experimental single case study. subjects completed Clincian-Adminestered PTSD Scale (CAPS), Beck Depression Inventory (BDI-II),Thought Control Questionnaire (TCQ) at pre-treatment(baseline), treatment (4 and 8 sessions), post-treatment (twelfth) and at follow-up (two months after treatment).

Results: Both combination of pharmachothrapy with metacognitive therapy and pharmachotherapy in patient with posttraumatic stress disorder are effective, and combination of pharmacotherapy with metacognitive therapy can be more effective.

Conclusion: Combination of pharmacotherapy with metacognitive therapy can be more effective than pharmachotherapy in reducing posttraumatic stress disorder symptoms.

Keywords

• metacognitive therapy
• Posttraumatic stress disorder
• Pharmachotherapy
• Depression
• Thought Control

Main Subjects

• clinical psychology